鼻副鼻腔疾患に伴う頭痛，顔面痛

2015電磁波＿歯科医.rtfd

2 (1) (2) SCI 2 SCI 2 24 2 12 2

2004 (1) (2) (2) (3) (1) 1 (2) (3) 2 (1) (2) SCI 2 SCI 2 24 2 12 2 100% / 16 2002 2003 http://lin.lin.go.jp/alic/month/dome/1997/nov/chousa.htm (05 612 1315 1618 1922 2329 3039 4049 5059 60 ) =10 b g 1

-2-

Super Lizer HT-2200 m m W Super Lizer -1- -2- -3- -4- stellate ganglion block stellate ganglion -5- -6- -7- -8- IgA -9- " " -10- -11- 5 6 10 1-12- -1- -2- mv -3- -4- -5- -1- : -2- No.2576 P.25 1973-3-

- 2 -

- 1 - - 2 - - 3 - - 4 - - 5 - ( ) - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - What is your hobby? - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27

,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,

1 1 1 2 1 3 1 4 2 5 5 6 6 1 6 2 7 3 7 4 7 5 7 7 8 8 10 1 10 2 10 3 10 12 1 12 2 12 3 12 4 13 5 14 14 1 14 1 2 3 4 5 1 2 3 4 16 5 16 6 16 7 17 6 17 18 19~23-19- 1 0.5 1 43.25 2.20 3.60 103.50 43.88 2.20

1 5 6 2 3 7 8 4 5 9 10 6 7 11 12 8 1 2 3 4 5 6 7 1989 25.0% 19901999 6 2000 15.0% 9 13 1 2 3 4 5 50 2 5180 45.0% 81 35.0%, 5.0% + +, 5.0% +, 1, 5 +, 3 14 10 0% 20% 40% 60% 80% 100% n=20 3 5 2 n=20 55.0%

2 3 1 1-2 -

; cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml Mφ 6 7, 8 9

32, 21-25, 2012 CASLE 1 1 80 26 6 5 4 cm 1 2 CEA 3 4 CEA 2 44 22 2 3 1.5 cm 22 1. 1 ; 6 5 4 cm 4. ; 2. ; 3. ; 5. 2 ; 120 ng/ml 0-40 5 Mφ 6 7, 8 9 23 6. ; 9. ; 7. ; 10. ; 8. 7 10 CK3 CK3 24 1,2 3 2 8% 4,5

好酸球性副鼻腔炎:診断ガイドライン（JESREC Study）

118 728 2015 : : JESREC Study Japanese Epidemiological Survey of Refractory Eosinophilic Chronic Rhinosinusitis Study : JESREC Study CT NSAIDs CT : JESREC Study JESREC Study 118 729 ph CTMRI Caldwell Luc

untitled

PISA

Digital Photo Professional Ver1.6（Windows）

Windows CT1-5193-000 CANON INC. 2005 J 1 2 3 4 s s s 1 1 s s s s s 1 1 a s s 1 s s 1 2 s a 1 s a 2 3 1 1 s a a 2 a 3 a s s 1 a a s a s s 1 s s 1 2 3 s 1 1 a 2 a 1 a s 2 3 1 1 s a 2 1 3 1 s a 2

アナウンスマニュアル

(1). (2). a. b. c. a. c. c. (3). 1 ( ) ( ) 2 (1). (2). (3). 3 () """" 4 ( ) ( ) ( ) ( ) 5 ( ) 6 () () () () () () () () () () () () () () () () () () () 7 () () () () () () () () () () () () () () () ()

H8.6 P.4-202-

橡ボーダーライン.PDF

1 ( ) ( ) 2 3 4 ( ) 5 6 7 8 9 10 11 12 13 14 ( ) 15 16 17 18 19 20 ( ) 21 22 23 24 ( ) 25 26 27 28 29 30 ( ) 31 To be or not to be 32 33 34 35 36 37 38 ( ) 39 40 41 42 43 44 45 46 47 48 ( ) 49 50 51 52

untitled

1. 1 2. 2 3.,1995 3 223119 3.1,, 4 3.2 NTT,2003 5 mile,2003 4.,, 6 , 2001 22 126 7 9 34 22 22 8 (139) 8 6. 6.1,,,,,, 9 6.2a Who What Whom When How Where 3 4 5 4 8 8 4, 7 6,,,, 2 or 3 6.2NGO NGO Who What

Microsoft Word - .....J.^...O.|Word.i10...j.doc

P 1. 2. R H C H, etc. R' n R' R C R'' R R H R R' R C C R R C R' R C R' R C C R 1-1 1-2 3. 1-3 1-4 4. 5. 1-5 5. 1-6 6. 10 1-7 7. 1-8 8. 2-1 2-2 2-3 9. 2-4 2-5 2-6 2-7 10. 2-8 10. 2-9 10. 2-10 10. 11. C

DF-200

がん診療におけるFDG FDG-PET/CTの役割

PET/CT PET/CT MRI PET PET/CT Kurashiki Central Hospital FDG-PET CT PET/CT (stage1) FDG-PET (stage1) PET/CT FDG-PET PET/CT (stage4) FDG-PET (stage4) PET/CT FDG-PET PET/CT PET/CT

untitled

210-0004 TEL 200-3298,3300 FAX 222-1442 14 ( ) 14 ( ) 7 ( ) 16 ( ) 16 ( ) 23 ( ) (%) 1 ( ) 1 ( ) 2 ( ) 7 ( ) 7 ( ) 22 ( ) 8 ( ) 22 ( ) 30 ( ) or 31( )

210-0004 TEL 200-3298,3300 FAX 222-1442 10:00 14:00 210-0004 TEL 200-3298,3300 FAX 222-1442 14 ( ) 14 ( ) 7 ( ) 16 ( ) 16 ( ) 23 ( ) (%) 1 ( ) 1 ( ) 2 ( ) 7 ( ) 7 ( ) 22 ( ) 8 ( ) 22 ( ) 30 ( ) or 31(

1 1 1 46111 2 1061.0 106.3 1/10 24721 90 25 1/4 243 3 23 25 1.4 512 120 280 260 100 240 220 80 200 180 160 60 140 120 40 100 80 20 60 40 20 0 0 55 56 57 58 59 60 61 62 63 2 3 4 5 6 7 8 9 10 11 12 13 14

4

4 r r 43 44 a b c f d e a r b c d e f 45 r r r 46 47 a b g a b r c d e f r g c d e f e 48 mm r r 1 49 a r b c a b 1 1 a 3 a 50 1 a 3 1 mb a 1 mm 3 a a a 51 1 mm 1 mm 1 5 mb 3 4 1 3 4 1 53 1 1 mj r 1 a

21 1 503604705 MRI CT 1 3 MRIMRS 5 5 5 5 5 6 7 8 17 1 17 2 17 3 17 4 18 5 19 21 1 23 2 1 27 3 2 48 4 3 88 5 105 6 110 7 118 MRS MRS ATP 312CT 65 60 1 2 1 1 1 2 1 2 2 X CT MRS 3 36657269 MRIMRS 1.5TMRSymphony

セゾン保険_PDF用.indd

講座の記録

橡Taro9-生徒の活動.PDF

3 1 4 1 20 30 2 2 3-1- 1 2-2- -3- 18 1200 1 4-4- -5- 15 5 25 5-6- 1 4 2 1 10 20 2 3-7- 1 2 3 150 431 338-8- 2 3 100 4 5 6 7 1-9- 1291-10 - -11 - 10 1 35 2 3 1866 68 4 1871 1873 5 6-12 - 1 2 3 4 1 4-13

untitled

10K1A NASA () SPACE ATLAS Freedom H2A NASA 1

10O1A 10 10 1 10K1A NASA () SPACE ATLAS 40 1957 1969 10 1986 1990 Freedom 20 000 H2A NASA 1 10K1A 100 10 21 40 1996 ( 200 () 2 10S1A 10 8 57 250 1 10S1A 20 200mmm 2 10S1B 18 18 1 10S1B 40 10 20 2 10S1C

E-mail [email protected] 2000. 2. 1-1-

E-mail [email protected] 2000. 2. 1-1- LD LD LD -2- MBD Minimal Brain Dysfunction Syndrome -3- Minimal Brain Dysfunction Syndrome : --- WISC-WPPSIK-ABC --- CTMRIEEG --- 40 60-4- -5- MBD MBD MBD MBD

untitled

NEDO

10 MRI 1 1 595% 5 IOR 100% MRI MRI MRI MRI MRI MRI 11 MRI 3 2 1 MRI 1 1.5 0.000005 100 5 MRI MRI MRI MRI MRI MRI MRI MRI MRI (1) MRI MRI 0.3 3 MRI 1 / (2) MRI MRI (3)MRI MRI 3 (4)MRI MRI MRI (5)MRI 2006

天草郡市医師会第139回(臨時)代議員会

A 97 2(B A2) 4(A B3) 2 95 B 104 25(A B3) 16(B A2) 9 113 201 27 20 7 208 2 1 13 3 18 4 19 3 3 2 2 13 4 17 3 18 6 26 6 30 17 18 17 17 17 17 18 ( ) 18 ( ) 18 ( ) 18 ( ) 18 ( ) ( ) ( ) ( ) ( ) ( ) 18 ( ) (

1 2 3 4 10 5 30 87 50 20 3 7 2 2 6 3 70 7 5 10 20 20 30 14 5 1,000 24 112 2 3 1 8 110 9 JR 10 110 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 25 30 31 32 25 A 33 B C D E F G PR PR or 34 35

437“ƒ

et al., et al., et al., et al., et al., et al., 2 et al., et al., et al., Lancet Pharmacol Res. et al. Jpn J Cancer Res. et al. Jpn J Cancer Res. et al. Tohoku J Exp Med. et al. Jpn Circ J. et al. Cancer

.H...A.....M.[00.\...\01.^.O.Z

1

1 2 3 4 5 0% 20% 40% 60% 80% 100% 6 7 8 0% 20% 40% 60% 80% 100% 9 0% 20% 40% 60% 80% 100% 10 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 2529 (n=17) 3034 35 (n=21) (n=17) 2529 (n=19) 3034 35 (n=34) (n=64)

[FX18]シリーズカタログ

ICR (db) 6 5 3 2 ICR 1 ICR IEEE spec 2 4 6 8 1 Z (Ohms) 11 15 1 95 Impedance 9.2.4.6.8 1 Time (ns) 213.9 FX18-6 S -.8 SH FX18-6 P -.8 SH FX18-6 P -.8 SV 1 FX18-6 S -.8 SV 15 FX18-6 PS -.8 H 15 Signal

耳展 長 32:6 舩 宏 隆,他 表2 症状 の改 善率 と臨床 病型 表3 レ線 的改 善率 と臨床 病 型 M.N. 14歳 臨 床 症型:浮 腫茸 状 型 手 術 法:両 前篩 骨 洞 開放 術 両 下鼻 道 開 窓術 治療 効 果:両 側著 明改 善 2年 術 前 術 後 症 例1 40 (550) 上 顎 洞 開 窓 術(小 児) 耳展 32:6 M.H. 13歳 臨床 病 型1浮 腫

untitled

Q 40 Q Q A 45 2 2 A 1 60 200 59.95 161 3 3 3 1 Q Q2 Q1 Q Q A2 1 2 Q Q Q Q Q Q A 32 2 U 3 4 Q Q Q Q 10 Q Q Q Q Q Q Q 22 Q Q Q 20 30 Q HP A 34 D K L L 5 Qmm Q 10 Q 21 Q Q Q Q Q Q Q A1 FRP 2 6 Q Q LDK Q Q

2011 2012 4 8 C D! A B

2011 2012 4 8 C D! A B C D 2013 2014 5/ 6 7 9 11/ 12 1 3 5/6 7 9 11/12 1 3 5 6 7 1971 2003118 9 196338) 7651) 2006 1 3 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 The Women of Lockerbie 19881221 16243

... 3 CT

CT915 ... 3 CT915... 4... 5... 6... 7... 11... 14... 16... 18... 19... 22... 24... 25... 26... 28... 29... 30... 31 2 3 CT915 120 120 1 1 31 31 4 CT915 s t CR2032 5 1. 2. 5 3. 6 CR2032 CR2032 1. / 1 2.

橡アロマセラピー症状別処方例.PDF

1 1 92 E 100ml 1 2 2 1 93 0.5m 10ml 100ml 1 2 3 2 52 0. l 2 4 3 27 3 1 1 3 3 4 5 3 2g 2 3 1 1 1 10ml 3 4 6 3 29 2 2 2 10ml 3 3 4 7 3 30 2 1 2 10ml 3 3 4 8 3 31 1 1 1 1 3 60 10 10 3 2 4 10ml A 2 3 61 20

QA Q1. A1. 118 2 Q2. A2. Q3. A3. 1) 2) 3) 4) 5) 6) 7) Q4. A4. 024-536-4343 10:0022:00 03-3264-4343 24 2008/10/15 1 1 2 3 2008/10/15 4: 5() N95 6A() SARS WHO B 7B( 1. 2. (( ) 3. 38 4. 5. 6. 2 2008/10/15

1 2 3 4

LC-32GH1 LC-32GH2 1 2 3 4 5 4 6 7 8 9 10 11 1 2 3 4444444444 4444444 444444444 OIL BAR BAR CLINIC CLINIC 1 2 1 2 1 2 3 4 1 2 1 2 See page 44 if you wish to display menu screens